|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
KR102375998B1
(ko)
|
2014-02-14 |
2022-03-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
키메라 항원 수용체 및 제조방법
|
|
CA2946312A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
FR3026744B1
(fr)
|
2014-10-06 |
2024-04-19 |
Hopitaux Paris Assist Publique |
Methode de generation de progeniteurs de cellules t
|
|
CA2964783C
(en)
|
2014-11-05 |
2024-01-23 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
FI3240805T3
(fi)
|
2014-12-15 |
2025-02-17 |
Univ California |
Cd19- ja cd20-vasteellinen bispesifinen tai-veräjän kimeerinen antigeenireseptori
|
|
US10808230B2
(en)
|
2015-02-24 |
2020-10-20 |
Board Of Regents, The University Of Texas System |
Selection methods for genetically-modified T cells
|
|
KR102615825B1
(ko)
|
2015-03-11 |
2023-12-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
전위효소 폴리펩타이드 및 이의 용도
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
EP3328994A4
(en)
|
2015-07-31 |
2019-04-17 |
Memorial Sloan-Kettering Cancer Center |
CD56-Faced Antigen-Binding Proteins and Uses Thereof
|
|
HK1258218A1
(zh)
|
2015-09-15 |
2019-11-08 |
Board Of Regents, The University Of Texas System |
T细胞受体(tcr)结合抗体及其应用
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
KR20180083874A
(ko)
*
|
2015-11-04 |
2018-07-23 |
사울 제이. 프라이스맨 |
Her2를 표적화하는 키메라 항원 수용체
|
|
CN108472317A
(zh)
*
|
2015-11-09 |
2018-08-31 |
爱普瑞希斯有限公司 |
修饰免疫细胞及其用途
|
|
US11034933B2
(en)
|
2016-01-28 |
2021-06-15 |
The Regents Of The University Of California |
Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection
|
|
IL287889B2
(en)
|
2016-02-05 |
2024-03-01 |
Hope City |
Administration of engineered t cells for treatment of cancers in the central nervous system
|
|
EP3439675A4
(en)
|
2016-04-08 |
2019-12-18 |
Purdue Research Foundation |
METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY
|
|
US20190119758A1
(en)
*
|
2016-04-22 |
2019-04-25 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
IL308798A
(en)
*
|
2016-06-06 |
2024-01-01 |
Univ Texas |
Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof
|
|
US20200208111A1
(en)
*
|
2016-06-09 |
2020-07-02 |
Branden S. Moriarity |
Genome-edited nk cell and methods of making and using
|
|
CN107523547A
(zh)
*
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
|
US11583555B2
(en)
|
2016-06-24 |
2023-02-21 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Genetic re-engineering of immune cells to improve metabolic fitness for immunotherapy
|
|
CN107663240B
(zh)
|
2016-07-29 |
2021-01-12 |
中国人民解放军第四军医大学 |
高度糖基化cea特异性结合的单链抗体及其在检测和治疗上的应用
|
|
CN109863242A
(zh)
|
2016-08-30 |
2019-06-07 |
纪念斯隆-凯特林癌症中心 |
用于治疗病毒感染和其它感染的免疫细胞组合物和使用方法
|
|
WO2018075830A1
(en)
|
2016-10-19 |
2018-04-26 |
Flodesign Sonics, Inc. |
Affinity cell extraction by acoustics
|
|
EP3567049A4
(en)
|
2016-12-28 |
2020-08-26 |
Green Cross Lab Cell Corporation |
CHEMERICAL ANTIGENIC RECEPTOR AND NATURAL KILLER CELLS EXPRESSING THE SAME
|
|
ES2931530T3
(es)
|
2017-02-13 |
2022-12-30 |
Hopitaux Paris Assist Publique |
Método para generar progenitores de células T
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
MX2019013514A
(es)
|
2017-05-12 |
2020-01-20 |
Crispr Therapeutics Ag |
Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
|
|
CN107099603A
(zh)
*
|
2017-05-31 |
2017-08-29 |
成都克里斯博生物科技有限公司 |
肿瘤免疫t细胞检测试剂盒和检测方法
|
|
GB201709203D0
(en)
|
2017-06-09 |
2017-07-26 |
Autolus Ltd |
Antigen-binding domain
|
|
CA3069527A1
(en)
*
|
2017-07-12 |
2019-01-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for treatment of cancers harboring an h3k27m mutation
|
|
CA3070998A1
(en)
*
|
2017-07-25 |
2019-01-31 |
Board Of Regents, The University Of Texas System |
Enhanced chimeric antigen receptors and use thereof
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
CN107287165A
(zh)
*
|
2017-08-23 |
2017-10-24 |
湖南开启时代生物科技有限责任公司 |
一种car‑t细胞的制备方法
|
|
US20200261502A1
(en)
*
|
2017-09-08 |
2020-08-20 |
Carsgen Therapeutics Co., Ltd. |
Genetically engineered t cell and application thereof
|
|
WO2019067243A1
(en)
|
2017-09-29 |
2019-04-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T CELL RECEPTORS RECOGNIZING P53 MUTE
|
|
CN107488738B
(zh)
*
|
2017-10-12 |
2020-04-28 |
中国医学科学院肿瘤医院 |
一种预测乳腺癌对曲妥珠单抗联合化疗治疗敏感性的生物标志物
|
|
WO2019094360A1
(en)
|
2017-11-07 |
2019-05-16 |
The Board Of Regents Of The University Of Texas System |
Targeting lilrb4 with car-t or car-nk cells in the treatment of cancer
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
KR102774451B1
(ko)
|
2017-11-14 |
2025-02-28 |
앱클론(주) |
항-her2 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 키메라 항원 수용체
|
|
JP7517983B2
(ja)
*
|
2017-11-20 |
2024-07-17 |
ユリウス－マクシミリアン－ウニヴェルシテート・ヴュルツブルク |
非常に低レベルのｃｄ１９を発現する骨髄腫細胞を除去するｃｄ１９ｃａｒｔ細胞
|
|
CU24558B1
(es)
*
|
2017-11-28 |
2021-12-08 |
Ct Inmunologia Molecular |
Anticuerpos monoclonales que reconocen al receptor del factor de crecimiento epidérmico y sus fragmentos derivados
|
|
CN108070033A
(zh)
*
|
2017-12-12 |
2018-05-25 |
武汉波睿达生物科技有限公司 |
一种3bnc-car分子的构建及其在杀灭hiv-1感染细胞中的应用
|
|
KR102439221B1
(ko)
|
2017-12-14 |
2022-09-01 |
프로디자인 소닉스, 인크. |
음향 트랜스듀서 구동기 및 제어기
|
|
EP3723774A4
(en)
*
|
2017-12-15 |
2021-09-08 |
The Board of Trustees of the Leland Stanford Junior University |
COMPOSITIONS AND METHODS OF INHIBITION OF T-CELL EXHAUSTATION
|
|
WO2019119822A1
(en)
|
2017-12-23 |
2019-06-27 |
Uwell Biopharma Inc. |
Pharmaceutical chimeric receptor composition and method thereof
|
|
EP3735265A4
(en)
|
2018-01-03 |
2021-11-10 |
Qu Biologics Inc. |
INNATE TARGETING OF ADOPTIVE CELL THERAPIES
|
|
US11965191B2
(en)
|
2018-01-18 |
2024-04-23 |
California Institute Of Technology |
Programmable protein circuits in living cells
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
EP3743083A4
(en)
|
2018-01-23 |
2021-11-03 |
Vanderbilt University |
SELF-ANTIGEN SPECIFIC T-LYMPHOCYTES AS VACCINES TO INCREASE ENGINEERING AND STABILITY OF AUTOLOGOUS TRANSFER
|
|
US12312416B2
(en)
|
2018-02-06 |
2025-05-27 |
Seattle Children's Hospital |
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors
|
|
AU2019225174B2
(en)
|
2018-02-23 |
2025-11-20 |
Endocyte, Inc. |
Sequencing method for CAR T cell therapy
|
|
CN112105723A
(zh)
*
|
2018-03-08 |
2020-12-18 |
鲁比厄斯治疗法股份有限公司 |
用于治疗癌症和传染病的治疗性细胞系统和方法
|
|
US20190247437A1
(en)
*
|
2018-04-19 |
2019-08-15 |
APDN (B.V.I.), Inc. |
Engineered lymphocyte compositions, methods and systems
|
|
MX2020012028A
(es)
|
2018-05-11 |
2021-03-29 |
Crispr Therapeutics Ag |
Metodos y composiciones para tratar el cancer.
|
|
AU2019301070B2
(en)
|
2018-07-09 |
2025-09-11 |
Precigen, Inc. |
Fusion constructs and methods of using thereof
|
|
CN112543651B
(zh)
*
|
2018-08-07 |
2023-06-02 |
普渡研究基金会 |
使car t细胞恢复活力
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
US11542305B2
(en)
|
2018-08-31 |
2023-01-03 |
California Institute Of Technology |
Synthetic protein circuits detecting signal transducer activity
|
|
KR20210056377A
(ko)
*
|
2018-09-07 |
2021-05-18 |
소티오, 엘엘씨 |
세포내 락테이트 농도를 조절하는 트랜스 대사 분자와 조합된 키메라 수용체 폴리펩타이드 및 이의 치료 용도
|
|
WO2020070290A1
(en)
*
|
2018-10-05 |
2020-04-09 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
WO2020146627A1
(en)
*
|
2019-01-10 |
2020-07-16 |
California Institute Of Technology |
A synthetic system for tunable thresholding of protein signals
|
|
WO2020154617A1
(en)
*
|
2019-01-25 |
2020-07-30 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting mutant ras
|
|
CA3130671A1
(en)
*
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas Systems |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
EP4414033A3
(en)
*
|
2019-02-08 |
2024-10-30 |
Biontech Cell & Gene Therapies Gmbh |
Treatment involving car-engineered t cells and cytokines
|
|
PE20211959A1
(es)
|
2019-02-15 |
2021-09-30 |
Editas Medicine Inc |
Celulas asesinas naturales (nk) modificadas para inmunoterapia
|
|
CN113874391B
(zh)
|
2019-02-20 |
2025-10-28 |
希望之城公司 |
靶向baff-r/cd19的嵌合抗原受体修饰的t细胞及其用途
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
MX2021013359A
(es)
|
2019-04-30 |
2022-01-31 |
Crispr Therapeutics Ag |
Terapia de celulas alogénicas de neoplasias malignas de células b usando células t modificadas genéticamente dirigidas a cd19.
|
|
CN114207136A
(zh)
*
|
2019-06-07 |
2022-03-18 |
朱诺治疗学股份有限公司 |
自动化t细胞培养
|
|
EP3980453A4
(en)
*
|
2019-06-07 |
2023-07-05 |
The Trustees of the University of Pennsylvania |
Dual car expressing t cells individually linked to cd28 and 4-1bb
|
|
WO2021050789A1
(en)
|
2019-09-10 |
2021-03-18 |
Obsidian Therapeutics, Inc. |
Ca2-il15 fusion proteins for tunable regulation
|
|
US20220387493A1
(en)
*
|
2019-11-06 |
2022-12-08 |
Baylor College Of Medicine |
Method for producing cytotoxic effector memory t-cells for car t-cell treatment of cancer
|
|
WO2021108543A1
(en)
*
|
2019-11-27 |
2021-06-03 |
The Trustees Of The University Of Pennsylvania |
Anti-cd3 scfv and cytokine producing artificial antigen presenting cells
|
|
CN115052887B
(zh)
*
|
2019-12-11 |
2026-03-31 |
A2生物治疗公司 |
基于lilrb1的嵌合抗原受体
|
|
CN115210252A
(zh)
|
2020-02-04 |
2022-10-18 |
西雅图儿童医院（Dba西雅图儿童研究所） |
抗二硝基苯酚的嵌合抗原受体
|
|
CN115427440A
(zh)
*
|
2020-02-25 |
2022-12-02 |
圭尔医疗有限公司 |
用于工程化细胞的嵌合受体
|
|
CN111253493B
(zh)
*
|
2020-03-05 |
2021-03-23 |
武汉科技大学 |
一种靶向hiv病毒囊膜双位点的嵌合抗原受体及其表达载体和应用
|
|
US12264190B2
(en)
*
|
2020-04-24 |
2025-04-01 |
Astrazeneca Ab |
Compositions and methods of treating cancer with chimeric antigen receptors
|
|
CN113913459A
(zh)
*
|
2020-07-09 |
2022-01-11 |
杭州优凯瑞医药科技有限公司 |
一种应用非病毒方法制备高纯度嵌合抗原受体修饰的t细胞的方法及其应用
|
|
WO2022011256A1
(en)
|
2020-07-10 |
2022-01-13 |
Precigen, Inc. |
Fusion constructs and methods of using thereof
|
|
KR102605723B1
(ko)
*
|
2020-11-11 |
2023-11-24 |
한국과학기술원 |
키메라 항원 수용체를 위한 타깃 항원 발굴 방법 및 분석 장치
|
|
CN114716548B
(zh)
*
|
2021-01-05 |
2024-11-05 |
(株)爱恩德生物 |
抗-fgfr3抗体及其用途
|
|
US20240327889A1
(en)
*
|
2021-04-05 |
2024-10-03 |
Victor TETS |
Regulation of cells and organisms
|
|
US20250073264A1
(en)
*
|
2021-04-08 |
2025-03-06 |
Artiva Biotherapeutics, Inc. |
Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the same
|
|
EP4359541A4
(en)
|
2021-06-23 |
2025-04-30 |
Editas Medicine, Inc. |
Engineered cells for therapy
|
|
CA3226947A1
(en)
|
2021-08-03 |
2023-02-09 |
Muhammad YASSIN |
Engineered tcr complex and methods of using same
|
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
|
EP4722239A2
(en)
*
|
2021-08-20 |
2026-04-08 |
Christopher E. Rudd |
Compositions and methods for anti-virus chimeric antigen receptor
|
|
US20250222029A1
(en)
*
|
2022-04-08 |
2025-07-10 |
Fate Therapeutics, Inc. |
Chimeric antigen receptor for tumor targeting
|
|
US20250228943A1
(en)
|
2022-04-08 |
2025-07-17 |
Fate Therapeutics, Inc. |
Cells having solid tumor targeting backbone and use thereof
|
|
CN115873803B
(zh)
*
|
2022-11-28 |
2025-06-17 |
上海恩凯细胞技术有限公司 |
提高nk细胞存活和抗肿瘤活性的方法及应用
|
|
WO2025106453A1
(en)
*
|
2023-11-13 |
2025-05-22 |
California Institute Of Technology |
Synpoptosis circuits for programmable cell death control
|
|
CN119080932A
(zh)
*
|
2024-09-02 |
2024-12-06 |
浙江大学 |
靶向表皮生长因子受体耐药性突变体的西妥昔单抗变体
|